The domain within your query sequence starts at position 661 and ends at position 707; the E-value for the KA1 domain shown below is 5.9e-22.
HENFVQWEMEVCKLPRLSLNGVRFKRISGTSMAFKNIASKIANELKL
KA1 |
---|
PFAM accession number: | PF02149 |
---|---|
Interpro abstract (IPR001772): | Members of the KIN2/PAR-1/MARK kinase subfamily are conserved from yeast to human and share the same domain organisation: an N-terminal kinase domain ( IPR000719 ) and a C-terminal kinase associated domain 1 (KA1). Some members of the KIN1/PAR-1/MARK family also contain an UBA domain ( IPR015940 ). Members of this kinase subfamily are involved in various biological processes such as cell polarity, cell cycle control, intracellular signalling, microtubule stability and protein stability [ (PUBMED:15182702) ]. The function of the KA1 domain is not yet known but several studies strongly suggest that it is involved in protein localisation. In addition, it has been reported that this C-terminal region acts as an autoinhibitory domain for the N‐terminal kinase domain [ (PUBMED:17075132) ]. Some proteins known to contain a KA1 domain are listed below:
The KA1 domain comprises about 50 amino acid residues and end in the highly conserved Glu‐Leu‐Lys‐Leu motif, termed the ELKL motif which forms a concave surface surrounded by positively charged residues, being important for the KA1 domain function. This domain adopts a compact alpha+beta structure with a beta-alpha-beta-beta-beta-beta-alpha topology [ (PUBMED:17075132) ]. |
This is a PFAM domain. For full annotation and more information, please see the PFAM entry KA1